SBC Medical Group Holdings Incorporated has recently released its 10-Q report, providing a detailed insight into its financial performance and operations. The company, headquartered in Irvine, California, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore.
In the 10-Q report, SBC Medical Group Holdings Incorporated reported generating revenues of $43,358,847 for the three months ended June 30, 2025, compared to $53,102,080 for the same period in 2024. The net income attributable to SBC Medical Group Holdings Incorporated was $2,458,240 for the three months ended June 30, 2025, a significant decrease from $18,484,408 for the same period in 2024. Additionally, the report revealed that the company reported cash flows provided by operating activities of $(6,411,168) for the three months ended June 30, 2025, compared to $22,874,760 for the same period in 2024.
The report also provided a breakdown of the company's revenues, indicating that franchising revenue decreased by 31.58%, procurement revenue increased by 16.40%, management services revenue decreased by 69.24%, rental services revenue increased by 98.40%, and other revenues increased by 17.25% for the three months ended June 30, 2025, compared to the same period in 2024.
Furthermore, the 10-Q report highlighted the factors contributing to the variance in revenues, net, for the three months ended June 30, 2025, including the impact of the Japanese Yen against the U.S. dollar.
The report also delved into the operating expenses, showing a breakdown of expenses such as salaries and welfare, depreciation and amortization expense, consulting and professional service fees, and advertising expense for the three months ended June 30, 2025, compared to the same period in 2024.
Today the company's shares have moved -5.29% to a price of $4.30. Check out the company's full 10-Q submission here.
